1. Home
  2. EXAS vs APG Comparison

EXAS vs APG Comparison

Compare EXAS & APG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • APG
  • Stock Information
  • Founded
  • EXAS 1995
  • APG 1926
  • Country
  • EXAS United States
  • APG United States
  • Employees
  • EXAS N/A
  • APG N/A
  • Industry
  • EXAS Medical Specialities
  • APG Engineering & Construction
  • Sector
  • EXAS Health Care
  • APG Consumer Discretionary
  • Exchange
  • EXAS Nasdaq
  • APG Nasdaq
  • Market Cap
  • EXAS 8.8B
  • APG 10.2B
  • IPO Year
  • EXAS N/A
  • APG N/A
  • Fundamental
  • Price
  • EXAS $43.06
  • APG $35.25
  • Analyst Decision
  • EXAS Strong Buy
  • APG Strong Buy
  • Analyst Count
  • EXAS 18
  • APG 8
  • Target Price
  • EXAS $70.59
  • APG $43.29
  • AVG Volume (30 Days)
  • EXAS 2.0M
  • APG 1.7M
  • Earning Date
  • EXAS 05-07-2025
  • APG 05-01-2025
  • Dividend Yield
  • EXAS N/A
  • APG N/A
  • EPS Growth
  • EXAS N/A
  • APG N/A
  • EPS
  • EXAS N/A
  • APG N/A
  • Revenue
  • EXAS $2,758,867,000.00
  • APG $7,018,000,000.00
  • Revenue This Year
  • EXAS $13.02
  • APG $6.60
  • Revenue Next Year
  • EXAS $13.02
  • APG $4.72
  • P/E Ratio
  • EXAS N/A
  • APG N/A
  • Revenue Growth
  • EXAS 10.37
  • APG 1.30
  • 52 Week Low
  • EXAS $40.62
  • APG $31.44
  • 52 Week High
  • EXAS $79.62
  • APG $41.31
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 36.15
  • APG 38.04
  • Support Level
  • EXAS $44.00
  • APG $36.67
  • Resistance Level
  • EXAS $47.23
  • APG $36.91
  • Average True Range (ATR)
  • EXAS 1.57
  • APG 1.01
  • MACD
  • EXAS 0.06
  • APG -0.15
  • Stochastic Oscillator
  • EXAS 15.86
  • APG 2.91

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.

About APG APi Group Corporation

APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.

Share on Social Networks: